Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
Top Cited Papers
- 28 May 2009
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 27, B3-B12
- https://doi.org/10.1016/j.vaccine.2009.04.071
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Henoch-Schonlein purpura and meningococcal B vaccinationArchives of Disease in Childhood, 2009
- The Intensive Vaccines Monitoring Programme (IVMP): An electronic system to monitor vaccine safety in New ZealandVaccine, 2008
- Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaksVaccine, 2007
- Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVsVaccine, 2007
- Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle VaccineClinical and Vaccine Immunology, 2006
- The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZBClinical and Vaccine Immunology, 2006
- Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidisVaccine, 2005
- The concept of “tailor-made”, protein-based, outer membrane vesicle vaccines against meningococcal diseaseVaccine, 2005
- Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infantsThe Journal of Pediatrics, 1992
- IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEINThe Lancet, 1986